Norway· NO-ID_70D09EF3-71C1-40F5-9F25-8C08DC44FACD

Levolac

A lactulose product containing lactulose + liquid, registered in Norway by Fresenius Kabi Austria GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC A06AD11

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedLevolacATCA06AD11REGISTER NO.NO-ID_70D09EF3-71C1-4…PACKS LISTED7CHECKEDSeptember 25, 2026

Where it is registered

Lactulose is registered in 16 of 19 countries.

Countries holding a registration under ATC A06AD11 (lactulose), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Lactulose · ATC A06AD11

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Lactulose + Liquid
Manufacturer
Fresenius Kabi Austria GmbH
Country
Norway (NO)
ATC code
A06AD11
ATC class
Lactulose
Defined daily dose
12.5 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 7

  • no_merkevare_id
    ID_70D09EF3-71C1-40F5-9F25-8C08DC44FACD
  • no_varenummer
    126517
    200
  • no_varenummer
    410356
    1000
  • no_varenummer
    150154
    500
  • gtin
    7046261265171
  • gtin
    7046264103562
  • gtin
    7046261501545

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

657 interactions on record for lactulose.

Graded by severity as the source publishes them — 263 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lactulose · interactions on record

657 records

  • 263 moderate
  • 18 minor
  • 376 info

Most severe, free to view

  • CisaprideA03FA02moderate
  • OndansetronA04AA01moderate
  • GranisetronA04AA02moderate
  • DolasetronA04AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac997b8c-2de0-4a9e-ade1-805f3ae3cf2f
GET /v1/drugs/ac997b8c-2de0-4a9e-ade1-805f3ae3cf2f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Mikstur, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Laktulose",
  "merkevare_id": "ID_70D09EF3-71C1-40F5-9F25-8C08DC44FACD",
  "name_form_strength": "Levolac mikst oppl 670 mg/ml",
  "prescription_group": "F"
}

See everything about lactulose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.